ArticleInvestigational new drugs2010

A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer.

Sang Joon Shin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.